Characterization of bone marrow cells for prognosis prediction of multiple myeloma using Raman spectroscopy with optimal discriminant model

Multiple Myeloma (MM) is a disease characterized by an increase in cancerous plasma cells, known as myeloma cells, which have differentiated from B cells and primarily reside in bone marrow. It usually develops from an asymptomatic precursor state, Monoclonal Gammopathy of Undetermined Significance (MGUS). MM generally has a poor prognosis. To distinguish Multiple Myeloma from its precursor state, which requires treatment, a comprehensive diagnosis is made through detailed examination of blood, urine, and bone marrow. The incidence of these diseases is known to increase with age. In this study, we propose a new diagnostic method for MM patients using Raman spectroscopy. This technique utilizes the interaction of light to obtain information on the molecular without labeling. Since it can be used in combination with conventional histopathological diagnosis through staining, this could lead to the development of models that are useful for clinical decision-making.

Authors

Publication Details

Published
2025-03-20
DOI
https://doi.org/10.1117/12.3046725
Primary Topic
Spectroscopy Techniques in Biomedical and Chemical Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Characterization of bone marrow cells for prognosis prediction of multiple myeloma using Raman spectroscopy with optimal discriminant model

S. Yonezawa, Keiichi Koizumi, Akinori Wada, Takayuki Haruki et al.
Spectroscopy Techniques in Biomedical and Chemical Research
article

Characterization of bone marrow cells for prognosis prediction of multiple myeloma using Raman spectroscopy with optimal discriminant model

S. Yonezawa, Keiichi Koizumi, Akinori Wada, Takayuki Haruki, Akinori Taketani, Yusuke Oshima, Tsutomu Sato
article en

Abstract

Multiple Myeloma (MM) is a disease characterized by an increase in cancerous plasma cells, known as myeloma cells, which have differentiated from B cells and primarily reside in bone marrow. It usually develops from an asymptomatic precursor state, Monoclonal Gammopathy of Undetermined Significance (MGUS). MM generally has a poor prognosis. To distinguish Multiple Myeloma from its precursor state, which requires treatment, a comprehensive diagnosis is made through detailed examination of blood, urine, and bone marrow. The incidence of these diseases is known to increase with age. In this study, we propose a new diagnostic method for MM patients using Raman spectroscopy. This technique utilizes the interaction of light to obtain information on the molecular without labeling. Since it can be used in combination with conventional histopathological diagnosis through staining, this could lead to the development of models that are useful for clinical decision-making.

Reduced inequalities
Openalex Percentile: Top 95%
Spectroscopy Techniques in Biomedical and Chemical Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Characterization of bone marrow cells for prognosis prediction of multiple myeloma using Raman spectroscopy with optimal discriminant model — S. Yonezawa, Keiichi Koizumi, et al. · (2025) | TGRS Research Map | TGRS